Autoimmune origin for immune checkpoint inhibitor-diabetes revealed by deep immune phenotyping of the pancreas.

Saved in:
Bibliographic Details
Title: Autoimmune origin for immune checkpoint inhibitor-diabetes revealed by deep immune phenotyping of the pancreas.
Authors: Quandt Z; Department of Medicine, University of California San Francisco, San Francisco, California, USA Zoe.Quandt@ucsf.edu.; Diabetes Center, University of California San Francisco, San Francisco, California, USA., Young A; Diabetes Center, University of California San Francisco, San Francisco, California, USA.; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Division of Microbiology and Immunology, Department of Pathology, University of Utah, Salt Lake City, Utah, USA., Barlow GL; Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.; Department of Pathology, Stanford University School of Medicine, Stanford, California, USA., Smith JA; Diabetes Center, University of California San Francisco, San Francisco, California, USA., Kusmartseva I; Department of Pathology, Immunology and Laboratory Medicine, University of Florida Diabetes Institute, Gainesville, Florida, USA., Dong S; Diabetes Center, University of California San Francisco, San Francisco, California, USA., Shapiro MR; Department of Pathology, Immunology and Laboratory Medicine, University of Florida Diabetes Institute, Gainesville, Florida, USA., Kang JH; Diabetes Center, University of California San Francisco, San Francisco, California, USA., Felton JL; Department of Pediatrics, Division of Pediatric Endocrinology and the Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana, USA.; Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, Indiana, USA., Nguyen VQ; Diabetes Center, University of California San Francisco, San Francisco, California, USA.; Department of Surgery, University of California San Francisco, San Francisco, California, USA., Szot G; Diabetes Center, University of California San Francisco, San Francisco, California, USA.; Department of Surgery, University of California San Francisco, San Francisco, California, USA., Hassoun AA; Department of Surgery, California Pacific Medical Center, San Francisco, California, USA.; Department of Surgery, Zheen International Hospital, Erbil, Iraq., Perdigoto AL; Department of Internal Medicine, Yale University, New Haven, Connecticut, USA.; Internal Medicine, VA Connecticut Healthcare System, West Haven, Connecticut, USA., Herold KC; Department of Internal Medicine, Yale University, New Haven, Connecticut, USA.; Department of Immunobiology, Yale University, New Haven, Connecticut, USA., Nolan G; Department of Pathology, Stanford University School of Medicine, Stanford, California, USA., Bollyky PL; Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA., Brusko TM; Department of Pathology, Immunology and Laboratory Medicine, University of Florida Diabetes Institute, Gainesville, Florida, USA.; Department of Pediatrics, University of Florida, Gainesville, Florida, USA.; Department of Biochemistry and Molecular Biology, University of Florida, Gainesville, Florida, USA., Nakayama M; Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, Colorado, USA.; Barbara Davis Center for Childhood Diabetes, University of Colorado School of Medicine, Aurora, Colorado, USA., Cooper S; Liver Center, University of California San Francisco, San Francisco, California, USA.; Division of General and Transplant Hepatology, California Pacific Medical Center, San Francisco, California, USA., Anderson MS; Department of Medicine, University of California San Francisco, San Francisco, California, USA.; Diabetes Center, University of California San Francisco, San Francisco, California, USA.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2025 Aug 14; Vol. 13 (8). Date of Electronic Publication: 2025 Aug 14.
Publication Type: Journal Article; Case Reports
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2051-1426
DOI:10.1136/jitc-2025-011818